NCT04220970

Breast Implant-associated Anaplastic Large Cell Lymphoma (BIA-ALCL) Registry

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 150 (estimated)
• Sponsor: The Lymphoma Academic Research Organisation · Academic / Other
• Sex: Female
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Anaplastic large cell lymphoma associated with breast implants (BIA-ALCL) is a rare disease seen only in women with a breast implant. Because of the low incidence of this disease and the peculiar histological subtype, French authorities, in accordance with the recommendations of an expert group, recommended the implementation of a BIA-ALCL case registry, in connection with a national Multidisciplinary meeting (Réunion de Concertation Pluridisciplinaire nationale de recours- RCP). This registry is opened in France and in Belgium

Conditions

• Anaplastic Large Cell Lymphoma Associated With Breast Implants (BIA-ALCL)

Interventions

Type	Name	Description
OTHER	BIA-ALCL	Observational : no intervention

Timeline

• Start date: 2017-06-07
• Primary completion: 2032-06-07
• Completion: 2032-06-07
• First posted: 2020-01-07
• Last updated: 2026-01-14

Locations

31 sites across 2 countries: Belgium, France